July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Management of early acute rejection of keratolimbal allografts: a case series.
Author Affiliations & Notes
  • Eubee B Koo
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida, United States
  • Allister Gibbons
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida, United States
  • Victor L Perez
    Ophthalmology, Duke, North Carolina, United States
  • Footnotes
    Commercial Relationships   Eubee Koo, None; Allister Gibbons, None; Victor Perez, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6315. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eubee B Koo, Allister Gibbons, Victor L Perez; Management of early acute rejection of keratolimbal allografts: a case series.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6315.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : While systemic immunosuppression is often required for long-term graft survival following keratolimbal allograft, the use of pulsed intravenous methylprednisolone in the face of early acute rejection is not well described. We report the presentation, management and outcomes of patients at our institution following early acute rejection after keratolimbal allograft (KLAL) surgery.

Methods : The medical records of all patients who underwent a KLAL at Bascom Palmer Eye Institute since 2006 were retrospectively reviewed for the occurrence of an acute rejection episode occurring within the 3-month post-operative period. Three cases were identified and reviewed for this series.

Results : All patients presented with an episode of rejection within one month of undergoing KLAL. All of them were under 50 years of age and on triple immunosuppressive regimen; however, there were documented issues with compliance. After treatment with pulsed intravenous methylprednisolone, along with education on medication adherence, KLAL function was restored in all three cases.

Conclusions : While compliance with immunosuppression is crucial in preventing graft rejection after KLAL, in cases where an early acute rejection episode occurs, prompt recognition and aggressive management with pulsed intravenous steroids can preserve graft function.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×